Alaunos Therapeutics, Inc. (TCRT)
1.855
+0.02
(+0.82%)
USD |
NASDAQ |
Nov 06, 09:58
Alaunos Therapeutics Max Drawdown (5Y) : 99.87% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.87% |
| September 30, 2026 | 99.84% |
| August 31, 2026 | 99.83% |
| July 31, 2026 | 99.83% |
| June 30, 2026 | 99.83% |
| May 31, 2026 | 99.83% |
| April 30, 2026 | 99.83% |
| March 31, 2026 | 99.83% |
| February 28, 2026 | 99.83% |
| January 31, 2026 | 99.83% |
| December 31, 2025 | 99.83% |
| November 30, 2025 | 99.83% |
| October 31, 2025 | 99.83% |
| September 30, 2025 | 99.83% |
| August 31, 2025 | 99.83% |
| July 31, 2025 | 99.83% |
| June 30, 2025 | 99.83% |
| May 31, 2025 | 99.83% |
| April 30, 2025 | 99.83% |
| March 31, 2025 | 99.83% |
| February 28, 2025 | 99.82% |
| January 31, 2025 | 99.80% |
| December 31, 2024 | 99.80% |
| November 30, 2024 | 99.76% |
| October 31, 2024 | 99.76% |
| Date | Value |
|---|---|
| September 30, 2024 | 99.74% |
| August 31, 2024 | 99.74% |
| July 31, 2024 | 99.64% |
| June 30, 2024 | 99.40% |
| May 31, 2024 | 99.36% |
| April 30, 2024 | 99.36% |
| March 31, 2024 | 99.36% |
| February 29, 2024 | 99.36% |
| January 31, 2024 | 99.36% |
| December 31, 2023 | 99.36% |
| November 30, 2023 | 99.09% |
| October 31, 2023 | 98.91% |
| September 30, 2023 | 98.24% |
| August 31, 2023 | 98.22% |
| July 31, 2023 | 94.54% |
| June 30, 2023 | 94.54% |
| May 31, 2023 | 94.54% |
| April 30, 2023 | 94.54% |
| March 31, 2023 | 94.54% |
| February 28, 2023 | 94.54% |
| January 31, 2023 | 94.54% |
| December 31, 2022 | 94.54% |
| November 30, 2022 | 94.54% |
| October 31, 2022 | 94.54% |
| September 30, 2022 | 94.54% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| Anika Therapeutics, Inc. | 83.15% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Imunon, Inc. | 99.54% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -56.81 |
| Beta (5Y) | -1.018 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 145.5% |
| Historical Sharpe Ratio (5Y) | -0.448 |
| Historical Sortino (5Y) | -1.181 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 46.40% |